Could cause temporary or reversible harm; serious harm is unlikely.
Failed Dissolution Specifications
| Brand name | POTASSIUM CHLORIDE |
| Generic name | POTASSIUM CHLORIDE |
| Active ingredient(s) | POTASSIUM CHLORIDE |
| Distributed by / for | Strides Pharma In., East Brunswick, NJ 08816 |
| NDC | 64380-861-07 |
| Full product label | Potassium Chloride Extended-Release Tablets, USP 10 mEq (750 mg), 500 Tablets, Rx Only, Manufactured by: Strides Shasun Limited, Bengaluru - 562106, India, Distributed by: Strides Pharma In., East Brunswick, NJ 08816, NDC 64380-861-07. |
| Recalling firm | Strides Pharma Inc. |
| Distribution | Nationwide |
| Quantity | 1813 bottles |
| Recall initiated | 2021-09-27 |
| Report date | 2021-10-20 |
| Recall completed | 2022-10-26 |
| Recall number | D-0006-2022 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | East Brunswick NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗